InvestorsHub Logo
Followers 4
Posts 189
Boards Moderated 0
Alias Born 04/19/2017

Re: None

Monday, 10/04/2021 9:40:55 AM

Monday, October 04, 2021 9:40:55 AM

Post# of 65617
"develop First in Class approaches towards diseases, which have significant possibility of sale or partnership with Big Pharma."

https://www.prnewswire.com/news-releases/therapeutic-solutions-international-utilizes-mesenchymal-stem-cell-exosomes-to-effectively-suppress-neutrophil-extracellular-trap-production-301391625.html

TSOI
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News